Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype
NCT ID: NCT06532734
Last Updated: 2025-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
25 participants
OBSERVATIONAL
2024-11-12
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Fecal Microbiome Transplant (FMT) Study for Anorexia Nervosa
NCT07143981
Whole Gut Microbiome Sequencing in Patients With Anorexia Nervosa
NCT02217384
Feasibility Study of Using Fecal Microbiota Transplants in Anorexia Nervosa
NCT05834010
Food Intake and IgA Microbiota in Anorexia Nervosa
NCT05842343
Fecal Microbiota Transplant for Anorexia Nervosa
NCT06593366
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AN-BP
individuals with a dx of AN-BP, with a \>5-year history of purging, with a frequency of at least once a day.
EsoGuard
device used to collect esophageal cell samples to test for the presence of abnormal cells which may indicate a dx of Barrett's esophagitis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EsoGuard
device used to collect esophageal cell samples to test for the presence of abnormal cells which may indicate a dx of Barrett's esophagitis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 18-65
* Purging history =\>5 years
* Purging or rumination at a minimum of once daily upon admission.
* Admission to the ACUTE Center for Eating Disorders and Severe Malnutrition
Exclusion Criteria
* Ages under 18 and over 65
* Patients who otherwise meet the current ACG screening guidelines (chronic GERD and 3 or more risk factors for Barrett's mentioned in the Background)
* Received mandated care at time of enrollment
* Inability to consent to participate in the research
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lucid Diagnostics, Inc.
INDUSTRY
Denver Health and Hospital Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Allison Nitsch
Lead Hospitalist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Allison Nitsch, MD
Role: PRINCIPAL_INVESTIGATOR
Denver Health and Hospital Authority
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ACUTE Center for Eating Disorders and Severe Malnutrition
Denver, Colorado, United States
Denver Health and Hospital Authority
Denver, Colorado, United States
Denver Health and Hospital Authority
Denver, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-0349
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.